Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs

被引：13
|
作者：
Ruilope, Luis M. [1 ,2 ,3 ,4 ]
Tamargo, Juan [5 ]
Ruiz-Hurtado, Gema [1 ,2 ,3 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Res I 12, Cardiorenal Translat Lab, Madrid, Spain
[2] Hosp Univ 12 Octubre, Inst Res I 12, Hypertens Unit, Madrid, Spain
[3] Hosp Univ 12 Octubre, CIBER CV, Madrid, Spain
[4] European Univ Madrid, Fac Sport Sci, Madrid, Spain
[5] Univ Complutense, Sch Med, Dept Pharmacol & Toxicol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷 / 22期
关键词：
D O I：
10.1093/eurheartj/ehaa487
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study'(dagger), by C. Gao et al., on page 2058.
引用
收藏
页码：2067 / 2069
页数：3
相关论文
共 50 条
  • [41] Renin-angiotensin system inhibition in COVID-19 patients
    de Vries, A. A. F.
    NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 396 - 405
  • [42] The renin-angiotensin system - a therapeutic target in COVID-19?
    Sturrock, Beattie R. H.
    Milne, Kate M.
    Chevassut, Timothy J. T.
    CLINICAL MEDICINE, 2020, 20 (04) : E72 - E75
  • [43] Renin-angiotensin system inhibition in COVID-19 patients
    A. A. F. de Vries
    Netherlands Heart Journal, 2020, 28 : 396 - 405
  • [44] Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study
    Miura, Ryosuke
    Okada, Kouji
    HYPERTENSION RESEARCH, 2023, 46 (12) : 2593 - 2602
  • [45] Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study
    Ryosuke Miura
    Kouji Okada
    Hypertension Research, 2023, 46 : 2593 - 2602
  • [46] INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM AS NEW ANTIHYPERTENSIVE AGENTS
    ANTONACCIO, MJ
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 27 - 46
  • [47] Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Burnier, Michel
    Oparil, Suzanne
    BLOOD PRESSURE, 2021, 30 (01) : 1 - 3
  • [48] Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators
    Wang, Tzung-Dau
    ACTA CARDIOLOGICA SINICA, 2020, 36 (03) : 179 - 182
  • [49] Renin-angiotensin system inhibitors and COVID-19: overwhelming evidence against an association Comment
    de Abajo, Francisco J.
    LANCET DIGITAL HEALTH, 2021, 3 (02): : E70 - E71
  • [50] Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19
    Theurl, Fabian
    Sappler, Nikolay
    Rizas, Konstantinos D.
    Massberg, Steffen
    Bauer, Axel
    Schreinlechner, Michael
    RESPIROLOGY, 2022, 27 (09) : 788 - 790
12345